Kenvue fights back against Tylenol safety concerns as its stock tumbles
Short excerpt below. Click through to read at the original source.
Kenvue rushed to the defense of Tylenol, but the stock still suffered a record selloff on news that RFK Jr. will release a report linking the use of acetaminophen during pregnancy to autism.